Paula Rangel-De la Mata

Paula Rangel-De la Mata

Auto-generated profile, based on publicly available information

Paula Rangel-De la Mata

FPSM research group - Physical Therapy Department, University of Alcalá de Henares, Alcalá de Henares, Madrid, Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in BMJ Open
Verified
Journal Article
Open access
María Torres-LacombaMaría Torres-Lacomba
María Torres-Lacomba
CHCarmen María Hernández-Iglesias
Carmen María Hernández-Iglesias
CVCristina del Valle-Rubido
Cristina del Valle-Rubido
Beatriz Navarro-BrazálezBeatriz Navarro-Brazález
Beatriz Navarro-Brazález
PMPaula Rangel-De la Mata
Paula Rangel-De la Mata
JFJesús Lázaro-Carrasco de la Fuente
Jesús Lázaro-Carrasco de la Fuente
Introduction: Genitourinary syndrome of menopause (GSM) is a prevalent condition among breast cancer survivors, often exacerbated by oncological treatments. Hormonal therapies are typically contraindicated in this population, necessitating effective non-hormonal interventions. Methods and analysis: This randomised controlled trial aims to compare the effectiveness and cost-effectiveness of multimodal pelvic floor physiotherapy—comprising pelvic floor muscle training, non-ablative radiofrequency, therapeutic pelvic health education and the use of vaginal moisturisers—versus fractional CO ₂ laser therapy combined with vaginal moisturisers in alleviating GSM symptoms in breast cancer survivors. Participants will be randomly assigned to one of the two intervention groups. Primary outcomes include measures of sexual function (assessed by the Female Sexual Function Index), subjective pelvic perineal pain intensity (measured with a 100 mm Visual Analogue Scale) and health-related quality of life (assessed by the Functional Assessment of Cancer Therapy-Breast), assessed at baseline, post-intervention and at 3, 6 and 12 months of follow-up. Statistical analyses will be conducted to evaluate the clinical efficacy and cost-effectiveness of the interventions. Ethics and dissemination: The study protocol has been approved by the Ethics and Health Research Committee of the University of Alcalá (Reference: CEIP/2024/1/012). All participants will provide informed consent prior to inclusion in the study. Findings will be disseminated through peer-reviewed journals and conference presentations, and by engaging with patient associations and survivor groups through tailored materials. Trial registration number: NCT06721936 .

6 April 2025 in Fisioterapia
Verified
Journal Article
Closed access
MVM. Blanco Vázquez
M. Blanco Vázquez
PMP. Rangel de la Mata
P. Rangel de la Mata
LLL. Lorenzo-Gallego
L. Lorenzo-Gallego
BNB. Navarro-Brazález
B. Navarro-Brazález